Special Issue "Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities"
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 16461
Interests: EV engineering; biotherpeutics delivery; RNA delivery
Interests: EV therapy; Cell therapy; EV diagnostics; Immunology; Transfusion Medicine.
Interests: extracellular vesicle flow cytometry; EV characterisation; EV production; EV heterogeneity; stem cells; EV diagnostics
Interests: liquid biopsies; RNA-sequencing; extracellular vesicles
Extracellular vesicles (EVs) are secreted by all cell types and can be found in all body fluids. EVs are intensely discussed and studied as potential new diagnostic biomarkers, and their ability to act as a natural vector offers a unique platform for the development of a new class of therapeutics. For example, unmodified EVs derived from mesenchymal stromal cells have demonstrated beneficial therapeutic effects in multiple animal disease models, and additionally EVs can be engineered to display various targeting and therapeutic moieties and shuttle cargo over biological barriers. Despite those prospects, many EV-related aspects related to EV production, isolation, formulation, cargo and function as well as their subsequent therapeutic application are yet poorly defined. This Special Issue has the aim to summarize the state-of-the-art, and the latest findings published within the field, as well as to elucidate future directions.
Dr. Samir EL Andaloussi
Dr. Joel Nordin
Dr. André Görgens
Dr. Daniel W. Hagey
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Extracellular Vesicles
- EVs, Exosomes
- EV engineering, protein engineering
- EV cargo